The global gastric cancer treatment market was valued at US$5.82 billion in 2024 and is expected to reach US$14.66 billion by 2033, expanding at a 10.9% CAGR as breakthroughs in targeted therapies like HER2 and CLDN18.2 agents transform treatment approaches https://www.datamintelligence.com/research-report/gastric-cancer-treatment-market